Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
CORT
↓ PDF (Pro)Corcept Therapeutics Incorporated Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$52.88
+3.00%today
MKT CAP
$5.7B
+20.6% · 1Y
Earnings History
+54.7%
+18.5%
-39.4%
-111.3%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$52.88
Low
$44.00
Analyst Mean
$73.40
High
$110.00
5 analystsBuy
Full Financials
Trailing P/E145.9x
Forward P/E31.3x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-18.4%
5y Revenue CAGR+23.7%
5y Earnings CAGR-1.0%
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership11.5%
Institutional Ownership71.7%
Short % of Float13.64%
Days to Cover5.9d
1 Week+10.6%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K | Chief Executive Officer | Sale | 40,000 | $50.10 | $2.00M | 2026-05-01 |
| WILSON JAMES N | Director | Stock | 2,000 | $0.00 | $0.00M | 2026-04-22 |
| GUYER WILLIAM | Officer | Sale | 20,000 | $40.97 | $0.82M | 2026-04-07 |
| GUYER WILLIAM | Officer | Conversion | 20,000 | $21.65 | $0.43M | 2026-04-07 |
| WILSON JAMES N | Director | Stock | 5,000 | $0.00 | $0.00M | 2026-04-06 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Blackrock Inc. | institution | 11.24% | $0.64B | +0.12% | 2025-12-31 |
| Vanguard Group Inc | institution | 8.84% | $0.50B | -0.44% | 2025-12-31 |
| Ingalls & Snyder LLC | institution | 6.70% | $0.38B | -6.53% | 2025-12-31 |
| Renaissance Technologies, LLC | institution | 5.36% | $0.30B | -5.43% | 2025-12-31 |
| iShares Trust-iShares Core S&P Small-Cap ETF | fund | 5.24% | $0.30B | -0.86% | 2026-03-31 |
| Parallel Advisors, LLC | institution | 3.61% | $0.21B | +0.20% | 2025-12-31 |
| State Street Corporation | institution | 2.78% | $0.16B | +0.53% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.63% | $0.15B | -0.15% | 2025-12-31 |
| Geode Capital Management, LLC | institution | 2.49% | $0.14B | +37.98% | 2025-12-31 |
| FMR, LLC | institution | 2.25% | $0.13B | +9.66% | 2025-12-31 |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | fund | 2.00% | $0.11B | -0.88% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | fund | 1.89% | $0.11B | -4.45% | 2025-12-31 |
| Dimensional Fund Advisors LP | institution | 1.51% | $0.09B | -14.38% | 2025-12-31 |
| Morgan Stanley | institution | 1.48% | $0.08B | +34.13% | 2025-12-31 |
| Fidelity Contrafund | fund | 1.11% | $0.06B | +12.01% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | fund | 1.07% | $0.06B | -3.54% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.94% | $0.05B | +0.48% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR Portfolio S&P 600 Small Cap ETF | fund | 0.79% | $0.04B | -2.61% | 2026-03-31 |
| iShares Trust-iShares S&P Small-Cap 600 Growth ETF | fund | 0.75% | $0.04B | +1.11% | 2026-03-31 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | fund | 0.60% | $0.03B | +100.00% | 2025-12-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for CORT.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.